{"id":"https://openalex.org/W4366351068","doi":"https://doi.org/10.1080/14712598.2023.2204186","title":"RE covery and SUR vival of patients with moderate to severe acute RE spiratory distress syndrome (ARDS) due to C OVID-19: a multicenter, single-arm, Phase IV itolizumab T rial: RESURRECT","display_name":"RE covery and SUR vival of patients with moderate to severe acute RE spiratory distress syndrome (ARDS) due to C OVID-19: a multicenter, single-arm, Phase IV itolizumab T rial: RESURRECT","publication_year":2023,"publication_date":"2023-04-19","ids":{"openalex":"https://openalex.org/W4366351068","doi":"https://doi.org/10.1080/14712598.2023.2204186","pmid":"https://pubmed.ncbi.nlm.nih.gov/37073744"},"language":"en","primary_location":{"id":"doi:10.1080/14712598.2023.2204186","doi":"https://doi.org/10.1080/14712598.2023.2204186","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1080/14712598.2023.2204186","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.medrxiv.org/content/medrxiv/early/2021/10/28/2021.10.25.21265462.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009953399","display_name":"Raveendra KR","orcid":"https://orcid.org/0000-0003-4246-9491","observed_orcids":["https://orcid.org/0000-0003-4246-9491"]},"institutions":[{"id":"https://openalex.org/I4210137705","display_name":"Victoria Hospital","ror":"https://ror.org/03q53r674","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210137705"]},{"id":"https://openalex.org/I876098953","display_name":"Bangalore Medical College and Research Institute","ror":"https://ror.org/05qmk4a18","country_code":"IN","type":"education","lineage":["https://openalex.org/I286135121","https://openalex.org/I876098953"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Raveendra KR","raw_affiliation_strings":["Department of Medicine, Victoria Hospital, Bangalore Medical College and Research Institute, Bangalore, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Victoria Hospital, Bangalore Medical College and Research Institute, Bangalore, Karnataka, India","institution_ids":["https://openalex.org/I4210137705","https://openalex.org/I876098953"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090286122","display_name":"Chirag Rathod","orcid":"https://orcid.org/0009-0006-2365-2302","observed_orcids":["https://orcid.org/0009-0006-2365-2302"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chirag Rathod","raw_affiliation_strings":["Department of Medicine, GMERS Medical College & Hospital, Old TB Hospital Campus, Vadodara, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, GMERS Medical College & Hospital, Old TB Hospital Campus, Vadodara, Gujarat, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009064163","display_name":"Rahul Darnule","orcid":"https://orcid.org/0000-0002-2147-7073","observed_orcids":["https://orcid.org/0000-0002-2147-7073"]},"institutions":[{"id":"https://openalex.org/I4210152189","display_name":"St. George Hospital","ror":"https://ror.org/05ghtc147","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210152189"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Rahul Darnule","raw_affiliation_strings":["Department of Medicine, Saint George\u2019s Hospital, Mumbai, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Saint George\u2019s Hospital, Mumbai, Maharashtra, India","institution_ids":["https://openalex.org/I4210152189"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041082309","display_name":"Subramanian Loganathan","orcid":"https://orcid.org/0000-0001-7186-0049","observed_orcids":["https://orcid.org/0000-0001-7186-0049"]},"institutions":[{"id":"https://openalex.org/I4210143327","display_name":"Biocon (India)","ror":"https://ror.org/047kynf18","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210143327"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Subramanian Loganathan","raw_affiliation_strings":["Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India"],"raw_orcid":"https://orcid.org/0000-0001-7186-0049","affiliations":[{"raw_affiliation_string":"Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India","institution_ids":["https://openalex.org/I4210143327"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003248622","display_name":"Sarika S Deodhar","orcid":"https://orcid.org/0000-0002-4010-8505","observed_orcids":["https://orcid.org/0000-0002-4010-8505"]},"institutions":[{"id":"https://openalex.org/I4210143327","display_name":"Biocon (India)","ror":"https://ror.org/047kynf18","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210143327"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Sarika Deodhar","raw_affiliation_strings":["Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India"],"raw_orcid":"https://orcid.org/0000-0002-4010-8505","affiliations":[{"raw_affiliation_string":"Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India","institution_ids":["https://openalex.org/I4210143327"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Radhika A","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143327","display_name":"Biocon (India)","ror":"https://ror.org/047kynf18","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210143327"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Radhika A","raw_affiliation_strings":["Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India","institution_ids":["https://openalex.org/I4210143327"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075141813","display_name":"Ashwani Marwah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143327","display_name":"Biocon (India)","ror":"https://ror.org/047kynf18","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210143327"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ashwani Marwah","raw_affiliation_strings":["Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India","institution_ids":["https://openalex.org/I4210143327"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050427504","display_name":"Nitin M Chaudhari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143327","display_name":"Biocon (India)","ror":"https://ror.org/047kynf18","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210143327"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Nitin M Chaudhari","raw_affiliation_strings":["Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India","institution_ids":["https://openalex.org/I4210143327"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036168521","display_name":"Binay K Thakur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143327","display_name":"Biocon (India)","ror":"https://ror.org/047kynf18","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210143327"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Binay K Thakur","raw_affiliation_strings":["Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India","institution_ids":["https://openalex.org/I4210143327"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110812060","display_name":"Sivakumar Vaidyanathan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143327","display_name":"Biocon (India)","ror":"https://ror.org/047kynf18","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210143327"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sivakumar Vaidyanathan","raw_affiliation_strings":["Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India","institution_ids":["https://openalex.org/I4210143327"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071740303","display_name":"Sandeep N. Athalye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143327","display_name":"Biocon (India)","ror":"https://ror.org/047kynf18","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210143327"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sandeep Nilkanth Athalye","raw_affiliation_strings":["Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India","institution_ids":["https://openalex.org/I4210143327"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5003248622"],"corresponding_institution_ids":["https://openalex.org/I4210143327"],"apc_list":null,"apc_paid":null,"fwci":0.3852,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.5283259,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"23","issue":"5","first_page":"443","last_page":"454"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10322","display_name":"Respiratory Support and Mechanisms","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/itolizumab","display_name":"itolizumab","score":0.9909999966621399},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9520000219345093},{"id":"https://openalex.org/keywords/acute-respiratory-distress-syndrome","display_name":"acute respiratory distress syndrome","score":0.9729999899864197},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.8659999966621399},{"id":"https://openalex.org/keywords/pao2-fio2-ratio","display_name":"PaO2/FiO2 ratio","score":0.8410000205039978},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.3409999907016754},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.7919999957084656},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.5299999713897705},{"id":"https://openalex.org/keywords/d-dimer","display_name":"D-dimer","score":0.5740000009536743},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.7990000247955322},{"id":"https://openalex.org/keywords/lactate-dehydrogenase","display_name":"lactate dehydrogenase","score":0.8130000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9009509086608887},{"id":"https://openalex.org/C2776348555","wikidata":"https://www.wikidata.org/wiki/Q344873","display_name":"ARDS","level":3,"score":0.8424497842788696},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.6059787273406982},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5869441628456116},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.5527867674827576},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.49175265431404114},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4718591868877411},{"id":"https://openalex.org/C179755657","wikidata":"https://www.wikidata.org/wiki/Q58702","display_name":"Mortality rate","level":2,"score":0.45720914006233215},{"id":"https://openalex.org/C76538665","wikidata":"https://www.wikidata.org/wiki/Q6294669","display_name":"Oxygen saturation","level":3,"score":0.44241863489151},{"id":"https://openalex.org/C2909621147","wikidata":"https://www.wikidata.org/wiki/Q344873","display_name":"Acute respiratory distress","level":3,"score":0.4376929998397827},{"id":"https://openalex.org/C2992435398","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter study","level":3,"score":0.4352002739906311},{"id":"https://openalex.org/C141983124","wikidata":"https://www.wikidata.org/wiki/Q188008","display_name":"Respiratory distress","level":2,"score":0.43326103687286377},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3465402126312256},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2812648415565491},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.22305458784103394},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.19192346930503845},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.11739611625671387},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.09900569915771484},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010100","descriptor_name":"Oxygen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012128","descriptor_name":"Respiratory Distress Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/14712598.2023.2204186","doi":"https://doi.org/10.1080/14712598.2023.2204186","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1080/14712598.2023.2204186","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},{"id":"doi:10.1101/2021.10.25.21265462","doi":"https://doi.org/10.1101/2021.10.25.21265462","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2021.10.25.21265462","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2021/10/28/2021.10.25.21265462.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},{"id":"pmid:37073744","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37073744","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on biological therapy","raw_type":"Multicenter Study"}],"best_oa_location":{"id":"doi:10.1101/2021.10.25.21265462","doi":"https://doi.org/10.1101/2021.10.25.21265462","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2021.10.25.21265462","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2021/10/28/2021.10.25.21265462.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4366351068.pdf","grobid_xml":"https://content.openalex.org/works/W4366351068.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W1489752262","https://openalex.org/W1872411639","https://openalex.org/W2014381340","https://openalex.org/W2082400280","https://openalex.org/W2139138993","https://openalex.org/W2161328469","https://openalex.org/W2588692501","https://openalex.org/W2731611291","https://openalex.org/W3001118548","https://openalex.org/W3015490759","https://openalex.org/W3016127406","https://openalex.org/W3018517500","https://openalex.org/W3021577619","https://openalex.org/W3021915688","https://openalex.org/W3027630905","https://openalex.org/W3034328821","https://openalex.org/W3041667892","https://openalex.org/W3044087915","https://openalex.org/W3044530856","https://openalex.org/W3093116912","https://openalex.org/W3093579719","https://openalex.org/W3102409480","https://openalex.org/W3103231362","https://openalex.org/W3109941542","https://openalex.org/W3110844195","https://openalex.org/W3118422118","https://openalex.org/W3127349317","https://openalex.org/W3128211804","https://openalex.org/W3129869280","https://openalex.org/W3131636786","https://openalex.org/W3131672926","https://openalex.org/W3136200818","https://openalex.org/W3138233671","https://openalex.org/W3141776090","https://openalex.org/W3146431923","https://openalex.org/W3151269380","https://openalex.org/W3186065996","https://openalex.org/W4206396480","https://openalex.org/W4206634366","https://openalex.org/W4281385307","https://openalex.org/W4281770725","https://openalex.org/W4292210633"],"related_works":["https://openalex.org/W3209304117","https://openalex.org/W3146431923","https://openalex.org/W4393383920","https://openalex.org/W3128211804","https://openalex.org/W4311359349","https://openalex.org/W3132714128","https://openalex.org/W4284989782","https://openalex.org/W3141776090","https://openalex.org/W4293203469","https://openalex.org/W3136200818"],"abstract_inverted_index":{"Background":[0],"Itolizumab,":[1],"an":[2],"anti-CD6":[3],"monoclonal":[4],"antibody,":[5],"down-regulates":[6],"COVID-19-mediated":[7],"inflammation":[8],"and":[9,24,41,61,85,102,115,147,159,165,174,186],"the":[10,22],"acute":[11,97,111],"effects":[12],"of":[13,26,77,95,109,213],"cytokine":[14],"release":[15],"syndrome.":[16],"This":[17,43],"study":[18,48],"aimed":[19],"to":[20,87,171,180],"evaluate":[21],"safety":[23,198],"efficacy":[25],"itolizumab":[27,78],"in":[28,203],"hospitalized":[29,51,204],"COVID-19":[30,68,205],"patients":[31,140,152],"with":[32,53,199],"PaO2/FiO2":[33],"ratio":[34],"(PFR)":[35],"\u2264200":[36],"requiring":[37],"oxygen":[38,58,155],"therapy.Research":[39],"design":[40],"methods":[42],"multicenter,":[44],"single-arm,":[45],"Phase":[46],"4":[47],"enrolled":[49],"300":[50],"adults":[52],"SARS-CoV-2":[54],"infection,":[55],"PFR":[56],"\u2264200,":[57],"saturation":[59],"\u226494%,":[60],"\u22651":[62],"elevated":[63],"inflammatory":[64],"markers":[65],"from":[66],"17":[67],"specific":[69],"tertiary":[70],"Indian":[71],"hospitals.":[72],"Patients":[73],"received":[74],"1.6":[75],"mg/kg":[76],"infusion,":[79],"were":[80,153,178],"assessed":[81],"for":[82,189],"1":[83,106,119],"month,":[84],"followed-up":[86],"Day":[88,129,137,149],"90.":[89,175],"Primary":[90],"outcome":[91],"measures":[92],"included":[93],"incidence":[94],"severe":[96,110],"infusion-related":[98],"reactions":[99],"(IRRs)":[100],"(\u2265Grade-3)":[101],"mortality":[103,116],"rate":[104,117,127],"at":[105,118,128],"month.Results":[107],"Incidence":[108],"IRRs":[112],"was":[113,121,131],"1.3%":[114],"month":[120],"6.7%":[122],"(n":[123,133],"=":[124,134],"20/300).":[125],"Mortality":[126],"90":[130],"8.0%":[132],"24/300).":[135],"By":[136],"7,":[138],"most":[139],"had":[141],"stable/improved":[142],"SpO2":[143],"without":[144],"increasing":[145],"FiO2":[146],"by":[148],"30,":[150],"91.7%":[151],"off":[154],"therapy.":[156],"Overall,":[157],"63":[158],"10":[160],"patients,":[161],"respectively,":[162],"reported":[163],"123":[164],"11":[166],"treatment-emergent":[167],"adverse":[168],"events":[169],"up":[170],"Days":[172],"30":[173],"No":[176],"deaths":[177],"attributable":[179],"itolizumab.":[181],"Patient-reported":[182],"outcomes":[183],"showed":[184],"gradual":[185],"significant":[187],"improvement":[188],"all":[190],"five":[191],"dimensions":[192],"on":[193],"EQ-5D-5L.Conclusion":[194],"Itolizumab":[195],"demonstrated":[196],"acceptable":[197],"a":[200],"favorable":[201],"prognosis":[202],"patients.Clinical":[206],"trial":[207],"registration":[208],"CTRI/2020/09/027941":[209],"(Clinical":[210],"Trials":[211],"Registry":[212],"India).":[214]},"counts_by_year":[{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2023-04-21T00:00:00"}